The Biden administration is claiming authority to seize patents to prevent price gouging of certain medications by the pharmaceutical industry. The administration unveiled the framework listing factors that government agencies should consider when exercising the controversial policy. That policy, known as march-in rights, breaks the patents on drugs developed with federal assistance but not widely […]